AllQuantitative Report
Argus•February 17, 2021
Argus•February 17, 2021SLP: Lowering target price to $89.00
Summary
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and c
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeActions
Download Full ReportRelated Reports
- Analyst Report: International Business Machines CorporationApr 25, 2024 •
IBM
- STAA: What does Argus have to say about STAA?Apr 24, 2024 •
STAA
- ADUS: Lowering target price to $99.00Apr 24, 2024 •
ADUS
- EXPO: What does Argus have to say about EXPO?Apr 24, 2024 •
EXPO
- OMCL: Raising target price to $23.00Apr 24, 2024 •
OMCL